NNT and Alzheimer disease: Furthermore, five of the identified lncRNAs––SNHG14/UBE3A-ATS, PART1, NNT-AS1, AC093010.3 and ARMCX5-GPRASP2––were evaluated as a potential combinatorial AD biomarker in two distinct AD cohorts [120].